Useful Information
Human arachidonate 12-lipoxygenase
PDB Code 3D3L Target Class Miscellaneous Target ALOX12 Alias 12-LOX, 12S-LOX, ALOX12, LOG12 Disease Area/Function cancer Date Deposited May 12 2008 Authors
About this structure
ALOX12 (12-LOX, platelet-type lipoxygenase 12, arachidonate 12-lipoxygenase 12S, E.C. 1.13.11.31) belongs to the class of lipoxygenases which are non-heme iron containing dioxygenases. Lipoxygenases add molecular oxygen into polyunsaturated fatty acids harboring cis double bonds. They are involved in a large variety of human diseases such as inflammatory diseases or cancer 1. In this class, ALOX12 catalyses the transformation of arachidonic acid to 12-hydroperoxyeicosatetraenoic acid (12S-HPETE)2.ALOX12 is a 663 amino-acid containing protein divided into two domains: a PLAT domain lying from residues 2 to 111 and the lipoxygenase domain lying from residues 121 to 655. Here we have solved the structure of the lipoxygenase domain (residues 172 to 662) and refined to a resolution of 2.6Å (PDB entry : 3D3L). The structure was solved with molecular replacement using the coordinates of the rabbit reticulocyte 15-lipoxygenase (PDB entry : 1LOX)3.
The asymmetric unit contains two similar monomers (RMSD = 0.5Å for 446 amino-acid superimposed) and one atom of iron per monomer. Each iron atom is chelating by His360, His365 and His540. Because of a C-terminus extension carried by the vector, the C-terminus carboxylate is not able to complete the chelation as it is in other lipoxygenases4. The iron chelation is thus completed in the ALOX12 structure by a water molecule. ALOX12 structure exhibits the lipoxygenase fold which is mainly an all-α fold with the exception of a 4 strand antiparallel β-sheet flanked by an α-helix. In our structure, the iron-containing active site is locked by the α-helix α1 (residues 181 to 196).
Further studies are in process to fully characterize the enzymatic and structural properties of ALOX12.
References
- Skrzypczak-Jankun, E., Chorostowska-Wynimko, J., Selman, S. H., Jankun, J. (2007). Lipoxygenases - a challenging problem in enzyme inhibition and drug development. Curr. Enzyme Inhib. 3, 119-132.
- Hamberg, M. & Samuelsson, B. (1974). Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci U S A 71, 3400-4.
- Gillmor, S. A., Villasenor, A., Fletterick, R., Sigal, E. & Browner, M. F. (1997). The structure of mammalian 15-lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity. Nat Struct Biol 4, 1003-9.
- Choi, J., Chon, J. K., Kim, S. & Shin, W. (2008). Conformational flexibility in mammalian 15S-lipoxygenase: Reinterpretation of the crystallographic data. Proteins 70, 1023-32.


